311
Views
6
CrossRef citations to date
0
Altmetric
Original Article

Risk of fractures in dermatitis herpetiformis and coeliac disease: a register-based study

, , , , , , , ORCID Icon, & show all
Pages 843-848 | Received 13 May 2019, Accepted 20 Jun 2019, Published online: 07 Jul 2019

References

  • Bai JC, Ciacci C, Melberg J. World Gastroenterology Organisation Global Guidelines: celiac disease february 2017. J Clin Gastroenterol. 2017;51:755–768.
  • Salmi TT, Hervonen K, Kautiainen H, et al. Prevalence and incidence of dermatitis herpetiformis: a 40-year prospective study from Finland. Br J Dermatol. 2011;165:354–359.
  • Reunala T, Salmi TT, Hervonen K, et al. Dermatitis herpetiformis: a common extraintestinal manifestation of coeliac disease. Nutrients. 2018;10:1–9.
  • Hall NJ, Rubin G, Charnock A. Systematic review: adherence to a gluten-free diet in adult patients with coeliac disease. Aliment Pharmacol Ther. 2009;30:315–330.
  • Zanchetta MB, Longobardi V, Bai JC. Bone and celiac disease. Curr Osteoporos Rep. 2016;14:43–48.
  • Heikkilä K, Pearce J, Mäki M, et al. Celiac disease and bone fractures: a systematic review and meta-analysis. J Clin Endocrinol Metab. 2015;100:25–34.
  • Pinto-Sánchez MIP, Mohaidle A, Baistrocchi A, et al. Risk of fracture in celiac disease: gender, dietary compliance, or both? World J Gastroenterol. 2011;17:3035–3042.
  • Di Stefano M, Jorizzo RA, Veneto G, et al. Bone mass and metabolism in dermatitis herpetiformis. Dig Dis Sci. 1999;44:2139–2143.
  • Lorinczy K, Juhász M, Csontos Á, et al. Does dermatitis herpetiformis result in bone loss as coeliac disease does? A cross sectional study. Rev Esp Enferm Dig. 2013;105:187–193.
  • Abuzakouk M, Barnes L, O’Gorman N, et al. Dermatitis herpetiformis: no evidence of bone disease despite evidence of enteropathy. Dig Dis Sci. 2007;52:659–664.
  • Lheure C, Ingen-Housz-Oro S, Guignard S, et al. Dermatitis herpetiformis and bone mineral density: analysis of a French cohort of 53 patients. Eur J Dermatol. 2017;27:353–358.
  • Valdimarsson T, Löfman O, Toss G, et al. Reversal of osteopenia with diet in adult coeliac disease Community Medicine. Gut. 1996;38:322–327.
  • Lewis NR, Logan RFA, Hubbard RB, et al. No increase in risk of fracture, malignancy or mortality in dermatitis herpetiformis: a cohort study. Aliment Pharmacol Ther. 2008;27:1140–1147.
  • Virta LJ, Kaukinen K, Collin P. Incidence and prevalence of diagnosed coeliac disease in Finland: Results of effective case finding in adults. Scand J Gastroenterol. 2009;44:933–938.
  • Kurppa K, Lauronen O, Collin P, et al. Factors associated with dietary adherence in celiac disease: a nationwide study. Digestion. 2012;86:309–314.
  • Hervonen K, Alakoski A, Salmi TT, et al. Reduced mortality in dermatitis herpetiformis: a population-based study of 476 patients. Br J Dermatol. 2012;167:1331–1337.
  • Zone JJ, Meyer LJ, Petersen MJ. Deposition of granular IgA relative to clinical lesions in dermatitis herpetiformis. Arch Dermatol. 1996;132:912–918.
  • No authors listed. PERFECT-PERFormance, Effectiveness and Cost of Treatment episodes. 2017 [cited 2018 Sept 17] Available from: http://www.thl.fi/en_US/web/en/project?id=21963
  • Smith JB, Tulloch JE, Meyer LJ, et al. The incidence and prevalence of dermatitis herpetiformis in Utah. Arch Dermatol. 1992;128:1608–1610.
  • Schweizer JJ, von Blomberg BME, Bueno-de Mesquita HB, et al. Coeliac disease in The Netherlands. Scand J Gastroenterol. 2004;39:359–364.
  • West J, Logan RFA, Card TR, et al. Fracture risk in people with celiac disease: a population-based cohort study. Gastroenterology. 2003;125:429–436.
  • Ludvigsson JF, Michaelsson K, Ekbom A, et al. Coeliac disease and the risk of fractures - A general population-based cohort study. Aliment Pharmacol Ther. 2006;25:273–285.
  • Stobaugh DJ, Deepak P, Ehrenpreis ED. Increased risk of osteoporosis-related fractures in patients with irritable bowel syndrome. Osteoporos Int. 2013;24:1169–1175.
  • Thomason K, West J, Logan RA, et al. Fracture experience of patients with coeliac disease: a population based survey. Gut. 2003;52:518–522.
  • Vestergaard P, Mosekilde L. Fracture risk in patients with celiac disease, Crohn’s disease, and ulcerative colitis: a nationwide follow-up study of 16,416 patients in Denmark. Am J Epidemiol. 2002;156:1.
  • Pasternack C, Mansikka E, Kaukinen K, et al. Self-reported fractures in dermatitis herpetiformis compared to coeliac disease. Nutrients. 2018;10:351.
  • Lebwohl B, Michaëlsson K, Green PHR, et al. Persistent mucosal damage and risk of fracture in celiac disease. J Clin Endocrinol Metab. 2014;99:609–616.
  • Vasquez H, Mazure R, Gonzalez D, et al. Risk of fractures in celiac disease patients: a cross-sectional, case-control study. Am J Gastroenterology. 2000;95:183–189.
  • Fuchs V, Kurppa K, Huhtala H, et al. Factors associated with long diagnostic delay in celiac disease. Scand J Gastroenterol. 2014;49:1304–1310.
  • Mansikka E, Salmi T, Kaukinen K, et al. Diagnostic delay in dermatitis herpetiformis in a high-prevalence area. Acta Derm Venerol. 2018;7:195–199.
  • Hervonen K, Salmi TT, Ilus T, et al. Dermatitis herpetiformis refractory to gluten-free dietary treatment. Acta Derm Venerol. 2016;96:82–87.
  • Ilus T, Lähdeaho M-L, Salmi T, et al. Persistent duodenal intraepithelial lymphocytosis despite a long-term strict gluten-free diet in celiac disease. Am J Gastroenterol. 2012;107:1563–1569.
  • Mansikka E, Hervonen K, Salmi TT, et al. The decreasing prevalence of severe villous atrophy in dermatitis herpetiformis: a 45-year experience in 393 patients. J Clin Gastroenterol. 2017;51:235–239.
  • Huttunen TT, Kannus P, Pihlajamaki H, et al. Pertrochanteric fracture of the femur in the Finnish National Hospital Discharge Register: validity of procedural coding, external cause for injury and diagnosis. BMC Musculoskelet Disord. 2014;15:95–98.
  • Viljamaa M, Kaukinen K, Huhtala H, et al. Coeliac disease, autoimmune diseases and gluten exposure. Scand J Gastroenterol. 2005;40:437–443.
  • Aromaa A, Koskinen S, editors. Health and functional capacity in Finland. Helsinki: Publications of the National Public Health Institute, 2004.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.